Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-06

FDA Approved: DASATINIB — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a generic version of dasatinib (DASATINIB) from Alembic Pharmaceuticals Limited under an Original Application. The approval makes a generic option …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DASATINIB (Dasatinib)

Snippet

ORIG AP for DASATINIB (DASATINIB)